Suppr超能文献

线粒体表观遗传学与神经胶质瘤:线粒体DNA和核DNA的表观遗传改变会改变线粒体DNA的表达,并促进神经胶质瘤的致病性。

Mitoepigenetics and gliomas: epigenetic alterations to mitochondrial DNA and nuclear DNA alter mtDNA expression and contribute to glioma pathogenicity.

作者信息

Grady Clare I, Walsh Lisa M, Heiss John D

机构信息

Neurosurgery, MedStar Georgetown University Hospital, Washington, DC, United States.

Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, Bethesda, MD, United States.

出版信息

Front Neurol. 2023 May 30;14:1154753. doi: 10.3389/fneur.2023.1154753. eCollection 2023.

Abstract

Epigenetic mechanisms allow cells to fine-tune gene expression in response to environmental stimuli. For decades, it has been known that mitochondria have genetic material. Still, only recently have studies shown that epigenetic factors regulate mitochondrial DNA (mtDNA) gene expression. Mitochondria regulate cellular proliferation, apoptosis, and energy metabolism, all critical areas of dysfunction in gliomas. Methylation of mtDNA, alterations in mtDNA packaging via mitochondrial transcription factor A (TFAM), and regulation of mtDNA transcription via the micro-RNAs (mir 23-b) and long noncoding RNAs [RNA mitochondrial RNA processing (RMRP)] have all been identified as contributing to glioma pathogenicity. Developing new interventions interfering with these pathways may improve glioma therapy.

摘要

表观遗传机制使细胞能够根据环境刺激精确调节基因表达。几十年来,人们已经知道线粒体含有遗传物质。然而,直到最近才有研究表明表观遗传因素可调节线粒体DNA(mtDNA)的基因表达。线粒体调节细胞增殖、凋亡和能量代谢,而这些都是胶质瘤功能障碍的关键领域。mtDNA的甲基化、通过线粒体转录因子A(TFAM)改变mtDNA包装,以及通过微小RNA(mir 23-b)和长链非编码RNA [RNA线粒体RNA加工(RMRP)]调节mtDNA转录,都已被确定与胶质瘤的致病性有关。开发干扰这些途径的新干预措施可能会改善胶质瘤的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff5/10270738/f39e7d21eb19/fneur-14-1154753-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验